Report AMR

About AMR

The usage of antimicrobials causes bacteria or pathogens to change over time and makes antimicrobial pharmaceuticals less effective. This process is called antimicrobial resistance (AMR). When AMR infections occur and antimicrobials become ineffective, these infections can in the worst cases be fatal. In Japan and overseas, more and more microbes are developing AMR. If the current situation continues unabated, the annual number of deaths due to AMR infections is projected to increase to about 10 million people globally by 2050.
HGPI issued calls for action on this issue and AMR Alliance Japan was established in November 2018 with the goal of driving discussions and promoting policies for AMR with representatives from industry, Government, academia, and civil society. In its role as secretariat of AMR Alliance Japan, HGPI works to formulate policy recommendations and to see those recommendations implemented.

[Urgent Recommendation] Recommendation for the Basic Policy on Economic and Fiscal Management and Reform 2022 (May 30, 2022)
2022-05-30

[Urgent Recommendation] Recommendation for the Basic Policy on Economic and Fiscal Manag ...>>

[Activity Report] Launch of New Website by AMED Public and Private Partnerships for Infectious Disease R&D (April 14, 2022)
2022-04-27

[Activity Report] Launch of New Website by AMED Public and Private Partnerships for Infe ...>>

[Activity Report] Himeji City becomes first municipality in Japan to issue declaration on the promotion of AMR countermeasures (February 21, 2022)
2022-04-25

[Activity Report] Himeji City becomes first municipality in Japan to issue declaration o ...>>

[Event Report] WHO Regional Committee for the Western Pacific Related Event: “AMR: A Global Health Crisis” (September 25, 2021)
2022-04-13

[Event Report] WHO Regional Committee for the Western Pacific Related Event: “AMR: A Glo ...>>

[Registration Closed] (Webinar) Making the ‘Silent Pandemic’ of AMR Heard: What Countries Leading the Charge Against AMR are Doing to Ensure their Populations are Protected (April 28, 2022)
2022-04-11

[Registration Closed] (Webinar) Making the ‘Silent Pandemic’ of AMR Heard: What Countrie ...>>

[Case Study] Koji Masuda and Kenji Ikeda “TDM Is Not Only for Safety, but for Ensuring Effectiveness” (AMR Alliance Japan, March 31, 2022)
2022-03-31

[Case Study] Koji Masuda and Kenji Ikeda “TDM Is Not Only for Safety, but for Ensuring E ...>>

[Patient’s Voice] Ms. Sachiko Ito – Non-Tuberculosis Mycobacterial Lung Disease (March 18, 2022)
2022-03-18

[Patient’s Voice] Ms. Sachiko Ito – Non-Tuberculosis Mycobacterial Lung Dise ...>>

[Activity Report] Submission of recommendations to Public Comment on the “Interim Report of the Global Health Strategy in Japan Toward the 2030 Sustainable Development Goals (SDGs)” (February 25, 2022)
2022-03-17

[Activity Report] Submission of recommendations to Public Comment on the “Interim ...>>

[Case Study] Keisuke Kagami and Mitsuru Sugawara “Thrombocytopenia Can be Avoided By Monitoring Linezolid Blood Levels – Enabling Long-Term Linezolid Use for the Successful Treatment of Refractory Pyogenic Spondylodiscitis” (AMR Alliance Japan, March 7, 2022)
2022-03-07

[Case Study] Keisuke Kagami and Mitsuru Sugawara “Thrombocytopenia Can be Avoided By Mon ...>>

[Case Study] Keisuke Kagami and Mitsuru Sugawara “Concomitant piperacillin-tazobactam and vancomycin use increases the risk of acute kidney injury.” (AMR Alliance Japan, February 22, 2022)
2022-02-22

[Case Study] Keisuke Kagami and Mitsuru Sugawara “Concomitant piperacillin-tazobactam an ...>>

[Event Report] The 101st HGPI Seminar Looking Back at the History of Infectious Diseases to Think About the Future of AMR Countermeasures – A Seminar in Commemoration of AMR Awareness Month (November 24, 2021)
2022-02-01

[Event Report] The 101st HGPI Seminar Looking Back at the History of Infectious Diseases ...>>

[In the Media] “Faster Response to Antimicrobial Resistant Bacteria” (The Nikkei Personal Opinion and Insight, December 20, 2021)
2022-01-14

[In the Media] “Faster Response to Antimicrobial Resistant Bacteria” (The Nikkei Persona ...>>

PageTop